LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,606 | 0.0% | 11,699 | 0.0% | 0.03% | -3.6% |
| Q2 2023 | $38,606 | -0.3% | 11,699 | 0.0% | 0.03% | -6.7% |
| Q1 2023 | $38,723 | -8.3% | 11,699 | 0.0% | 0.03% | -14.3% |
| Q4 2022 | $42,233 | -59.4% | 11,699 | 0.0% | 0.04% | -63.9% |
| Q3 2022 | $104,000 | -64.1% | 11,699 | -66.7% | 0.10% | +90.2% |
| Q2 2022 | $290,000 | +163.6% | 35,097 | +200.0% | 0.05% | -7.3% |
| Q1 2022 | $110,000 | +35.8% | 11,699 | 0.0% | 0.06% | +25.0% |
| Q4 2021 | $81,000 | -27.7% | 11,699 | -0.5% | 0.04% | -27.9% |
| Q3 2021 | $112,000 | -37.1% | 11,760 | 0.0% | 0.06% | -34.4% |
| Q2 2021 | $178,000 | +29.0% | 11,760 | 0.0% | 0.09% | +20.8% |
| Q1 2021 | $138,000 | -67.1% | 11,760 | 0.0% | 0.08% | -70.4% |
| Q4 2020 | $420,000 | +157.7% | 11,760 | 0.0% | 0.26% | +132.1% |
| Q3 2020 | $163,000 | -16.0% | 11,760 | 0.0% | 0.11% | -23.3% |
| Q2 2020 | $194,000 | +94.0% | 11,760 | 0.0% | 0.15% | +84.8% |
| Q1 2020 | $100,000 | – | 11,760 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 153,867 | $507,761 | 0.30% |
| Lion Point Capital, LP | 78,351 | $258,558 | 0.12% |
| Minerva Advisors LLC | 26,549 | $84 | 0.06% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 31,088 | $102,591 | 0.02% |
| Greenwich Wealth Management LLC | 49,002 | $162 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |